US6183444B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug delivery module
Assignee: Boston Scientific Corp
•
Filing: 1998-05-16
•
Granted: 2001-02-06
•
Expires: 2018-05-16
Abstract
Abstract A modular drug delivery system for use by cardiothoracic surgeons and interventional cardiologists for delivery of molecular and cellular therapies that target genes, molecules and peptides. The regulated drug delivery devices comprise a modular mechanically actuated drug delivery module (DDM) that can be attached to either a surgical viewing endoscope hand-piece or specialized catheter for interventional procedures. The DDM provides metering of drugs to treatment sites and allows for quick interchangeability with other component parts such as a viewing scope end portion for MIS or other surgical procedures or a flexible catheter shaft for percutaneous procedures.
Inventors
- 👤 Robert C. Glines
- 👤 Richard D. Phipps
- 👤 Lauren Lundquist
- 👤 Daniel S. Brown
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:44
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/34; A61B17/3478; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B18/00; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00392; A61M; A61M5/00; A61M5/178; A61M5/31; A61M2005/3125; A61M25/00; A61M25/0021; A61M25/0023; A61M25/0026; A61M2025/0039; A61M25/0067; A61M25/0082; A61M25/0084; A61M2025/0089; A61M25/01; A61M25/0105; A61M25/0133; A61M25/0147; A61M5/315; A61M5/31525; A61M5/31531; A61M5/31533; A61M5/31545; A61M5/31548; A61M5/3155; A61M5/31553; A61M5/31561; A61M5/31563; A61M5/31565; A61M5/31576; A61M5/31578; A61M5/31581; A61M5/3159; A61M5/31593; A61M5/32; A61M5/3287
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
221 words
A drug delivery device for medicating internal tissue during minimally invasive surgery and/or other surgical procedures, the device comprising: (a) a drug delivery needle having a piercing tip and attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) an actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drug delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means also mounted within the housing; (c) a body member at the proximal end of said drug conduit, said body member adapted for connecting a visualization scope thereto, the body member being attached to the housing; and (d) an introducer having a length sufficient to reach a treatment site at target tissue, the introducer defining a working channel wherein the advanceable drug delivery needle with attached drug conduit is disposed therein, the piercing tip of the drug delivery needle being egressable at the introducer's distal end.
Claim 2
Dependent Claim
221 words
A drug delivery device for medicating internal tissue during minimally invasive surgery and/or other surgical procedures, the device comprising: (a) a drug delivery needle having a piercing tip and attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) an actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drug delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means also mounted within the housing; (c) a body member at the proximal end of said drug conduit, said body member adapted for connecting a visualization scope thereto, the body member being attached to the housing; and (d) an introducer having a length sufficient to reach a treatment site at target tissue, the introducer defining a working channel wherein the advanceable drug delivery needle with attached drug conduit is disposed therein, the piercing tip of the drug delivery needle being egressable at the introducer's distal end.
Claim 3
Dependent Claim
54 words
The device of claim 1 which further comprises a rigid endoscope having a visualization scope, the introducer further including: (i) a rigid tubular member that slidably encompasses the endoscope; and (ii) a transparent distal tip member that encloses the tubular member's distal end, said tip member enabling visualization of the working channel's distal end.
Claim 4
Dependent Claim
35 words
The device of claim 2 , wherein the tubular member and the transparent distal tip member form a unitary member made of an optically transparent polymer material, the unitary member having a uniform wall thickness.
Claim 5
Dependent Claim
53 words
The device of claim 2 , wherein the endoscope's distal end is essentially normal to the axis of the introducer, thereby providing visualization in a forward direction, and the working channel directs the piercing tip of the drug delivery needle past the introducer's distal end at an angle essentially parallel to the introducer.
Claim 6
Dependent Claim
51 words
The device of claim 2 , wherein the endoscope's distal end is essentially normal to the axis of the introducer, thereby providing visualization in a forward direction, and the working channel directs the piercing tip of the drug delivery needle past the introducer's distal end at an angle to the introducer.
Claim 7
Dependent Claim
67 words
The device of claim 2 , wherein the endoscope's distal end is at an angle with respect to an axis of the introducer, thereby providing visualization in a direction at an angle to the axis of the introducer, and the working channel directs the piercing tip of the drug delivery needle past the introducer's distal end in a direction essentially parallel to the axis of the introducer.
Claim 8
Dependent Claim
65 words
The device of claim 2 , wherein the endoscope's distal end is at an angle with respect to an axis of the introducer, thereby providing visualization in a direction at an angle to the axis of the introducer, and the working channel directs the piercing tip of the drug delivery needle past the introducer's distal tip at an angle to the axis of the introduce.
Claim 9
Dependent Claim
198 words
A drug delivery device for medicating internal body tissue during catheter and/or other percutaneous procedures, the device comprising: (a) a drug delivery needle having a piercing tip, said needle being attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drug delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means mounted within the housing; (c) an introducer having a length sufficient to reach a treatment site at target tissue, the introducer being attached to the quick-disconnect interface, the introducer defining at least one working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the introducer's distal end.
Claim 10
Dependent Claim
198 words
A drug delivery device for medicating internal body tissue during catheter and/or other percutaneous procedures, the device comprising: (a) a drug delivery needle having a piercing tip, said needle being attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drug delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means mounted within the housing; (c) an introducer having a length sufficient to reach a treatment site at target tissue, the introducer being attached to the quick-disconnect interface, the introducer defining at least one working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the introducer's distal end.
Claim 11
Dependent Claim
279 words
A detachable drug delivery module kit for visualizing and medicating internal body tissue during MIS and other surgical procedures and for catheter and/or percutaneous procedures, the kit comprising: (a) a drug delivery needle having a piercing tip, said needle being attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drum delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means also mounted within the housing; (c) a visualization scope having a body member for attachment to said housing, said visualization scope including a viewing means for optical viewing at the distal end of the drug conduit; (d) an endoscope-type introducer having a length sufficient to reach a treatment site, the endoscope-type introducer defining a working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the endoscope-type introducer's distal end; and (e) a catheter introducer having a length sufficient to reach a treatment site, the catheter introducer defining a working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the catheter introducer's distal end.
Claim 12
Dependent Claim
279 words
A detachable drug delivery module kit for visualizing and medicating internal body tissue during MIS and other surgical procedures and for catheter and/or percutaneous procedures, the kit comprising: (a) a drug delivery needle having a piercing tip, said needle being attached to a distal end of a drug conduit, the drug conduit also having a proximal end; and (b) a detachable drug delivery module for metering the drug, the detachable drug delivery module including: (i) a housing having a quick-disconnect interface for coupling to said drug conduit; (ii) at least one drug reservoir communicating with the drug conduit, the at least one reservoir mounted within the housing; and (iii) actuating means for (1) advancing the drug delivery needle, (2) displacing drug from the at least one reservoir through the drum delivery needle via the drug conduit, and (3) retracting the drug delivery needle, the actuating means also mounted within the housing; (c) a visualization scope having a body member for attachment to said housing, said visualization scope including a viewing means for optical viewing at the distal end of the drug conduit; (d) an endoscope-type introducer having a length sufficient to reach a treatment site, the endoscope-type introducer defining a working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the endoscope-type introducer's distal end; and (e) a catheter introducer having a length sufficient to reach a treatment site, the catheter introducer defining a working channel in which said drug delivery needle and said drug conduit are disposed, the piercing tip of the drug delivery needle being egressable at the catheter introducer's distal end.
References Cited (Backward Citations)
US2491978A
Cited
US4243035A
Cited
US4576591A
Cited
US4861339A
Cited
US5034003A
Cited
US5106370A
Cited
US5228883A
Cited
US5395312A
Cited
US5322511A
Cited
US5569160A
Cited
US5492119A
Cited
US5380279A
Cited
US5840059A
Cited
US5865811A
Cited
US5846225A
Cited
US5951516A
Cited
US5997509A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-02-06 | 2004-08-07 | 2005-02-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-02-06 | 2008-08-07 | 2009-02-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-02-06 | 2012-08-07 | 2013-02-06 | $7700.00 | Window Closed / Lapsed |